Go to content
UR Home

Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab

URN to cite this document:
DOI to cite this document:
Magnus, Clara Luzia ; Hiergeist, Andreas ; Schuster, Philipp ; Rohrhofer, Anette ; Medenbach, Jan ; Gessner, André ; Peterhoff, David ; Schmidt, Barbara
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 09 Sep 2022 13:06


Class 1 and 2 monoclonal antibodies inhibit SARS-CoV-2 entry by blocking the interaction of the viral receptor-binding domain with angiotensin-converting enzyme 2 (ACE2), while class 3 antibodies target a highly conserved epitope outside the ACE2 binding site. We aimed to investigate the plasticity of the spike protein by propagating wild-type SARS-CoV-2 in the presence of class 3 antibody S309. ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons